INTERLEUKIN (IL)-15 IS A NOVEL CYTOKINE THAT ACTIVATES HUMAN NATURAL-KILLER-CELLS VIA COMPONENTS OF THE IL-2 RECEPTOR

被引:978
作者
CARSON, WE
GIRI, JG
LINDEMANN, MJ
LINETT, ML
AHDIEH, M
PAXTON, R
ANDERSON, D
EISENMANN, J
GRABSTEIN, K
CALIGIURI, MA
机构
[1] ROSWELL PK CANC INST,DEPT MED,BUFFALO,NY 14263
[2] ROSWELL PK CANC INST,DEPT SURG,BUFFALO,NY 14263
[3] ROSWELL PK CANC INST,DEPT MOLEC MED,BUFFALO,NY 14263
[4] IMMUNEX RES & DEV CORP,SEATTLE,WA 98101
关键词
D O I
10.1084/jem.180.4.1395
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin 15 (IL-15) is a novel cytokine that has recently been cloned and expressed. Whereas it has no sequence homology with IL-2, IL-15 interacts with components of the IL-2 receptor (IL-2R). In the present study we performed a functional analysis of recombinant IL-15 on phenotypically and functionally distinct populations of highly purified human natural killer (NK) cells. The CD56(bright) subset of human NK cells constitutively expresses the high affinity IL-2R and exhibits a brisk proliferative response after the binding of picomolar amounts of IL-2. Using a proliferation assay, IL-15 demonstrated a very steep dose-response curve that was distinct from the dose-response curve for IL-2. The proliferative effects of IL-15 could be abrogated by anti-IL-2R beta (p75), but not by anti-IL-2R alpha (p55). The proliferative effects of IL-2 on CD56(bright) NK cells could be inhibited by both antibodies. CD56(dim) NK cells express the intermediate affinity IL-2R in the absence of the high affinity IL-2R. Activation of CD56(dim) NK cells by IL-15 was similar to that of IL-2 as measured by enhanced NK cytotoxic activity, antibody-dependent cellular cytotoxicity, and NK cell production of interferon gamma, tumor necrosis factor alpha, and granulocyte/macrophage colony-stimulating factor. The IL-15-enhanced NK cytotoxic activity could be completely blocked by anti-IL-2R beta monoclonal antibody. The binding of radiolabeled IL-2 and IL-15 to CD56(dim) NK cells was inhibited in the presence of anti-IL-2R beta. Scatchard analysis of radiolabeled IL-15 and IL-2 binding to NK-enriched human lymphocytes revealed the presence of high and intermediate affinity receptors for both ligands. IL-15 is a ligand that activates human NK cells through components of the IL-2R in a pattern that is similar but not identical to that of IL-2. Unlike IL-2, IL-15 is produced by activated monocytes/macrophages. The discovery of IL-15 may increase our understanding of how monocytes/macrophages participate in the regulation of NK cell function.
引用
收藏
页码:1395 / 1403
页数:9
相关论文
共 25 条
[1]   THE ROLE OF NATURAL-KILLER-CELLS IN INNATE RESISTANCE TO INFECTION [J].
BANCROFT, GJ .
CURRENT OPINION IN IMMUNOLOGY, 1993, 5 (04) :503-510
[2]   SELECTIVE MODULATION OF HUMAN NATURAL-KILLER-CELLS INVIVO AFTER PROLONGED INFUSION OF LOW-DOSE RECOMBINANT INTERLEUKIN-2 [J].
CALIGIURI, MA ;
MURRAY, C ;
ROBERTSON, MJ ;
WANG, E ;
COCHRAN, K ;
CAMERON, C ;
SCHOW, P ;
ROSS, ME ;
KLUMPP, TR ;
SOIFFER, RJ ;
SMITH, KA ;
RITZ, J .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (01) :123-132
[3]   FUNCTIONAL CONSEQUENCES OF INTERLEUKIN-2 RECEPTOR EXPRESSION ON RESTING HUMAN-LYMPHOCYTES - IDENTIFICATION OF A NOVEL NATURAL-KILLER-CELL SUBSET WITH HIGH-AFFINITY RECEPTORS [J].
CALIGIURI, MA ;
ZMUIDZINAS, A ;
MANLEY, TJ ;
LEVINE, H ;
SMITH, KA ;
RITZ, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (05) :1509-1526
[4]   NATURAL-KILLER (NK) CELL STIMULATORY FACTOR INCREASES THE CYTOTOXIC ACTIVITY OF NK CELLS FROM BOTH HEALTHY DONORS AND HUMAN-IMMUNODEFICIENCY-VIRUS INFECTED PATIENTS [J].
CHEHIMI, J ;
STARR, SE ;
FRANK, I ;
RENGARAJU, M ;
JACKSON, SJ ;
LLANES, C ;
KOBAYASHI, M ;
PERUSSIA, B ;
YOUNG, D ;
NICKBARG, E ;
WOLF, SF ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (03) :789-796
[5]  
DOWER SK, 1984, J IMMUNOL, V132, P751
[6]   INTERLEUKIN-12 IS REQUIRED FOR THE T-LYMPHOCYTE-INDEPENDENT INDUCTION OF INTERFERON-GAMMA BY AN INTRACELLULAR PARASITE AND INDUCES RESISTANCE IN T-CELL-DEFICIENT HOSTS [J].
GAZZINELLI, RT ;
HIENY, S ;
WYNN, TA ;
WOLF, S ;
SHER, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (13) :6115-6119
[7]   UTILIZATION OF THE BETA-CHAIN AND GAMMA-CHAIN OF THE IL-2 RECEPTOR BY THE NOVEL CYTOKINE-IL-15 [J].
GIRI, JG ;
AHDIEH, M ;
EISENMAN, J ;
SHANEBECK, K ;
GRABSTEIN, K ;
KUMAKI, S ;
NAMEN, A ;
PARK, LS ;
COSMAN, D ;
ANDERSON, D .
EMBO JOURNAL, 1994, 13 (12) :2822-2830
[8]   CLONING OF A T-CELL GROWTH-FACTOR THAT INTERACTS WITH THE BETA-CHAIN OF THE INTERLEUKIN-2 RECEPTOR [J].
GRABSTEIN, KH ;
EISENMAN, J ;
SHANEBECK, K ;
RAUCH, C ;
SRINIVASAN, S ;
FUNG, V ;
BEERS, C ;
RICHARDSON, J ;
SCHOENBORN, MA ;
AHDIEH, M ;
JOHNSON, L ;
ALDERSON, MR ;
WATSON, JD ;
ANDERSON, DM ;
GIRI, JG .
SCIENCE, 1994, 264 (5161) :965-968
[9]   IDENTIFICATION AND PURIFICATION OF NATURAL-KILLER CELL STIMULATORY FACTOR (NKSF), A CYTOKINE WITH MULTIPLE BIOLOGIC EFFECTS ON HUMAN-LYMPHOCYTES [J].
KOBAYASHI, M ;
FITZ, L ;
RYAN, M ;
HEWICK, RM ;
CLARK, SC ;
CHAN, S ;
LOUDON, R ;
SHERMAN, F ;
PERUSSIA, B ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (03) :827-845
[10]   A MONOCLONAL-ANTIBODY THAT APPEARS TO RECOGNIZE THE RECEPTOR FOR HUMAN T-CELL GROWTH-FACTOR - PARTIAL CHARACTERIZATION OF THE RECEPTOR [J].
LEONARD, WJ ;
DEPPER, JM ;
UCHIYAMA, T ;
SMITH, KA ;
WALDMANN, TA ;
GREENE, WC .
NATURE, 1982, 300 (5889) :267-269